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Selective tubular activation of 
hypoxia-inducible factor-2α has 
dual effects on renal fibrosis
Kyoung Hye Kong1, Hyung Jung Oh2, Beom Jin Lim3, Minsuk Kim4, Ki-Hwan Han4, Youn-Hee 
Choi4,5, Kihwan Kwon4, Bo Young Nam3, Kyoung Sook Park3, Jung Tak Park3, Seung Hyeok 
Han  3, Tae-Hyun Yoo3, Shina Lee4, Seung-Jung Kim4, Duk-Hee Kang4, Kyu Bok Choi4, Vera 
Eremina6, Susan E. Quaggin7, Dong-Ryeol Ryu  4,5 & Shin-Wook Kang3
Hypoxia-inducible factor (HIF) is a key transcriptional factor in the response to hypoxia. Although the 
effect of HIF activation in chronic kidney disease (CKD) has been widely evaluated, the results have 
been inconsistent until now. This study aimed to investigate the effects of HIF-2α activation on renal 
fibrosis according to the activation timing in inducible tubule-specific transgenic mice with non-diabetic 
CKD. HIF-2α activation in renal tubular cells upregulated mRNA and protein expressions of fibronectin 
and type 1 collagen associated with the activation of p38 mitogen-activated protein kinase. In CKD 
mice, activation of HIF-2α at the beginning of CKD significantly aggravated renal fibrosis, whereas 
it did not lead to renal dysfunction. However, activation at a late-stage of CKD abrogated both renal 
dysfunction and fibrosis, which was associated with restoration of renal vasculature and amelioration 
of hypoxia through increased renal tubular expression of VEGF and its isoforms. As with tubular cells 
with HIF-2α activation, those under hypoxia also upregulated VEGF, fibronectin, and type 1 collagen 
expressions associated with HIF-1α activation. In conclusion, late-stage renal tubular HIF-2α activation 
has protective effects on renal fibrosis and the resultant renal dysfunction, thus it could represent a 
therapeutic target in late stage of CKD.
Regardless of the type of initial injury to the kidney, renal hypoxia is the common final pathway of renal fibrosis1, 
which is regarded a prime target for preventing the progression of chronic kidney disease (CKD) to end-stage 
renal disease.
Hypoxia-inducible factor (HIF) is a key transcriptional factor in the regulation of the adaptive response to 
hypoxia. HIF is a heterodimeric complex that has three forms (HIF-1, HIF-2, and HIF-3), which differ in their 
α-subunit. If the α-subunit is not hydroxylated by prolyl hydroxylase under hypoxic conditions, it cannot be 
recognized by von Hippel-Lindau tumor suppressor protein (pVHL), which is part of an E3-ubiquitin ligase com-
plex that targets HIF-α for proteosomal degradation2. Then, α-subunit combines with a constitutively expressed 
β-subunit in the nucleus. Finally, HIF regulates the expression of salient target genes that are involved in numer-
ous biological processes, including energy metabolism, angiogenesis, erythropoiesis, iron metabolism, cell pro-
liferation, and apoptosis2.
HIF activation ameliorates tissue hypoxia and eventually helps the hypoxic cells survive. Even though the 
effect of HIF activation in CKD has been widely evaluated, the results have been inconsistent. Reduced renal 
fibrosis by genetic ablation of tubular HIF-1 suggested a profibrotic role of HIF3, while contrary results demon-
strated that an HIF stabilizer exerted a beneficial effect on renal fibrosis in an animal model of CKD4.
Accumulating evidence suggests that HIFs exert beneficial effects in diabetic nephropathy. Activation of HIFs 
by cobalt chloride, a non-specific pan-HIF activator, attenuated diabetes-induced alteration in oxygen metabolism 
1Graduate School, Ewha Womans University, Seoul, Korea. 2Ewha Institute of Convergence Medicine, Ewha Womans 
University, Seoul, Korea. 3College of Medicine, Yonsei University, Seoul, Korea. 4School of Medicine, Ewha Womans 
University, Seoul, Korea. 5Tissue Injury Defense Research Center, Ewha Womans University, Seoul, Korea. 6The 
Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada. 7Feinberg Cardiovascular Research Institute and 
Division of Nephrology and Hypertension, Northwestern University, Chicago, Illinois, USA. Kyoung Hye Kong and 
Hyung Jung Oh contributed equally to this work. Correspondence and requests for materials should be addressed to 
D.-R.R. (email: drryu@ewha.ac.kr) or S.-W.K. (email: kswkidney@yuhs.ac)
Received: 14 October 2016
Accepted: 30 August 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENTIFIC REPORTS | 7: 11351  | DOI:10.1038/s41598-017-11829-2
and mitochondrial leak respiration, proteinuria, and tubulointerstitial damage5, 6. However, in non-diabetic CKD, 
findings are largely conflicting. Renal fibrosis was aggravated in nephrectomized VHL–/– mice7, in which HIFs 
are activated in the whole body from the embryonic stage, and it was abrogated in genetically HIF-1-ablated mice 
with unilateral ureteral obstruction (UUO)3, suggesting a profibrotic role of HIF. In contrast, cobalt chloride 
administration ameliorated cyclosporine A-induced afferent arteriolopathy and tubulointerstitial injury in the 
kidney8. Moreover, peritubular capillary networks were preserved in cobalt chloride-treated rats with remnant 
kidneys9.
In this study, we aimed to investigate the impact of tubular HIF-2α activation on renal fibrosis according to 
the timing of activation.
Results
Generation of mice with inducible renal tubular HIF-2α activation. We used a transgenic mouse 
line containing hemagglutinin (HA)-tagged HIF2dPA, which escapes from recognition by pVHL owing to 
a proline to alanine substitution, preceded by a floxed stop codon cassette, rendering HIF-2α expression 
Cre-dependent.
To activate HIF-2α gene expression in renal tubular cells at the intended time, DOX has been added for 3 days 
and we bred HIF2dPA-HA mice10 with mice carrying tetO-Cre and Pax8-rtTA transgenes (Fig. 1A).
The induction of HIF-2α-HA protein expression in renal tubular cells was verified using by western blotting 
and immunofluorescent staining after doxycycline (DOX) administration. HIF-2α-HA protein was expressed in 
the transgenic mice, whereas it was hardly detected in the wild-type mice (Fig. 1B,C). The immunofluorescent 
signal of HIF-2α was observed in the nucleus as well as the cytoplasm of renal tubular cells (Fig. 1C). Figure 1D 
is the diagram depicting the scheme of animal experiments to investigate the impact of renal tubular HIF-2α 
activation on renal fibrosis according to the timing of HIF activation. Renal fibrosis and CKD was induced in 
wild-type and transgenic mice by feeding the mice a diet containing 0.2% adenine for 2 or 4 weeks. Mice fed with 
a conventional diet were used as controls.
Figure 1. Breeding strategy and the experimental design. (A) Breeding strategy to make transgenic (Tg) mice 
in renal tubular cells. (B,C) Immunofluorescent staining and western blot analysis using anti-hemagglutin (HA) 
antibody (n = 3 per group) or anti-HIF-2α antibody (n = 4 per group). The cropped blots are displayed; full-
length blots are presented in Supplementary Fig. 5. (D) Design for the timing effect of renal tubular selective 
HIF-2α activation. **P < 0.01 vs. WT mice; bar graphs show mean ± SEM. Scale bars, 20 μm.
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Renal dysfunction is ameliorated by late, but not by early HIF-2α activation in CKD mice 
model. There were no differences in body weight between wild-type and transgenic mice at both 2 weeks and 
4 weeks (Table 1). Body weights of wild-type CKD mice tended to be lower without statistical significance com-
pared to controls, whereas those of all transgenic CKD mice were significantly lower than those of controls. Body 
weights of transgenic mice at baseline before HIF-2α gene induction were lower than that of wild-type mice, and 
those were significantly decreased after CKD induction in both wild-type and transgenic mice, whereas those of 
transgenic mice with normal diet did not decrease (Supplementary Table 1).
Blood urea nitrogen (BUN) levels were significantly higher in CKD mice at 2 weeks (85.6 ± 11.4 mg/dL) and 
at 4 weeks (102.9 ± 8.7 mg/dL) than in control mice (28.3 ± 1.6 mg/dL) (P < 0.001 and P < 0.0001, respectively). 
Similarly, serum creatinine (Cr) concentrations were significantly higher in CKD mice at 2 weeks (0.61 ± 0.07 mg/
dL) and 4 weeks (0.79 ± 0.05 mg/dL) than in the controls (0.25 ± 0.01 mg/dL) (P < 0.001 and P < 0.001, respec-
tively). At 2 weeks, transgenic CKD mice with HIF-2α activation from the beginning of the 0.2% adenine diet 
showed BUN (74.3 ± 5.6 mg/dL) and Cr levels (0.56 ± 0.05 mg/dL) comparable to those of wild-type CKD mice 
(Table 1). Similarly, at 4 weeks after simultaneous HIF-2α activation and CKD induction, there were no signif-
icant differences in BUN (91.9 ± 7.5 mg/dL) and Cr concentrations (0.71 ± 0.05 mg/dL) between wild-type and 
transgenic CKD mice. In contrast, HIF-2α activation after 2 weeks of CKD induction significantly attenuated 
the increases in the BUN (73.0 ± 7.5 mg/dL, P < 0.01) and Cr levels (0.63 ± 0.02 mg/dL, P < 0.05) compared to 
wild-type CKD mice at 4 weeks.
Tubular HIF-2α activation aggravates renal fibrosis at the initial stage of CKD, but inhibits 
fibrosis progression at an advanced stage of CKD. We confirmed whether DOX-induced HIF-2α acti-
vation modified tubular HIF-2α protein expression or not. HIF-2α expression in the tubular cells of transgenic 
mice was significantly higher than that of both controls and corresponding wild-type mice by DOX administra-
tion (Fig. 2A and Supplementary Fig. 1).
Next, we investigated whether the timing of HIF-2α activation had differential effects on renal fibrosis by 
examining relevant protein expression and renal histology. Fibronectin protein expression was significantly 
higher in wild-type CKD mice at both 2 weeks and 4 weeks than in control mice (P < 0.001 and P < 0.001, 
respectively) (Fig. 2A). In addition, compared to wild-type CKD mice, the protein expression of fibronectin was 
1.28-fold higher at 2 weeks (P < 0.05) and 1.20-fold higher at 4 weeks (P < 0.05) in transgenic CKD mice after 
simultaneous CKD induction and HIF-2α activation. However, when HIF-2α was activated at 2 weeks after 
CKD induction, the increase in fibronectin protein expression at 4 weeks was significantly abrogated by 31.6% 
(P < 0.001) as compared to wild-type CKD mice. Type 1 collagen protein expression was changed in a similar way.
The western blot results for fibronectin were confirmed by Masson’s trichrome and Sirius red staining 
(Fig. 2B). Quantification of renal fibrosis using gray-scale images of Sirius red staining captured under a polar-
ized microscope revealed that renal fibrosis in wild-type CKD mice at 4 weeks was significantly ameliorated by 
HIF-2α activation at a later period but not by HIF-2α activation from the beginning of CKD induction (Fig. 2B 
and Supplementary Fig. 2).
Later renal tubular HIF-2α activation restores reduced renal vasculature in CKD mice and 
consequently improves the level of hypoxia. Western blot and immunofluorescent staining for the 
endothelial marker protein CD31 revealed that its expression in the kidneys at 2 weeks was significantly lower in 
wild-type CKD mice than in control mice, whereas it was significantly higher in HIF-2α transgenic CKD mice 
than in wild-type CKD mice (Fig. 3A,B). However, at 4 weeks of CKD, renal CD31 protein expression depended 
on the timing of HIF-2α transgene induction; it was significantly higher in transgenic CKD mice with later 
HIF-2α activation than in control mice as well as transgenic CKD mice with HIF-2α activation from the begin-
ning of CKD induction.
To identify renal hypoxia in CKD mice, we performed immunohistochemical staining for pimonidazole, a 
hypoxia marker. In the kidneys of CKD mice, immunoreactivity for pimonidazole was significantly greater than 
in control mice at both 2 and 4 weeks (Fig. 3C). There was no significant difference in immunoreactivity between 
wild-type and 2-week or 4-week transgenic CKD mice with HIF-2α activation from the beginning of CKD induc-
tion. However, the increase in pimonidazole-positive tubules at 4 weeks of CKD was significantly abrogated when 
HIF-2α was activated at a later period.
The mRNA expression of total vascular endothelial growth factor (VEGF) was significantly lower in wild-type 
CKD mice than that in controls at both 2 and 4 weeks (Supplementary Fig. 3). However, it was significantly higher 
in HIF-2α transgenic CKD mice than that in wild-type CKD mice at both 2 and 4 weeks, and there was more 
Parameters Control
At 2 weeks At 4 weeks
WT Tg WT Tg (DOX at D0) Tg (DOX at D14)
Body Weight (g) 26.7 ± 1.1 23.5 ± 0.9 22.3 ± 0.8* 23.5 ± 1.3 21.3 ± 0.8* 20.9 ± 1.0**
BUN (mg/dL) 28.3 ± 1.6 85.6 ± 11.4*** 74.3 ± 5.6*** 102.9 ± 8.7*** 91.9 ± 7.5*** 73.0 ± 7.5***, ##
Serum creatinine 
(mg/dL) 0.25 ± 0.01 0.61 ± 0.07
*** 0.56 ± 0.05*** 0.79 ± 0.05***, †† 0.71 ± 0.05*** 0.63 ± 0.02***, #
Table 1. Animal data of control mice, and wild-type and HIF-2α transgenic CKD mice at 2 weeks and 4 weeks. 
CKD, chronic kidney disease; BUN, blood urea nitrogen; WT, wild-type; Tg, transgenic; DOX, doxycycline. 
*P < 0.05, **P < 0.01, and ***P < 0.001, and vs. controls; #P < 0.05, and ##P < 0.01 vs. WT mice at 4 weeks; 
††P < 0.01 vs. WT mice at 2 weeks.
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significant increase in transgenic mice with later HIF-2α activation than those of all other groups. The mRNA 
expressions of VEGF 120, 164, and 188 isoforms were lower in wild-type and HIF-2α transgenic CKD mice com-
pared to controls at 2 weeks, whereas the decrement in mRNA expressions of VEGF isoforms in wild-type CKD 
mice significantly increased in HIF-2α transgenic CKD mice without regard to the activation timing at 4 weeks.
HIF-2α overexpression affects the expression of various genes in isolated primary TECs. After 
isolation of TECs from transgenic mice, DOX was added in the media at a final concentration of 1 μg/mL or 5 μg/
mL for transgene induction. We demonstrated that there was no significant cytotoxicity at these concentrations 
of DOX by the MTS assay (data not shown). TECs cultured in the media with DOX showed significantly higher 
HIF-2α protein expression in western blotting and immunofluorescent staining, and HIF-2α migrated into the 
nucleus at both concentrations of DOX. Moreover, the ratios in cultured cells with 1 μg/mL and 5 μg/mL DOX 
supplementation were significantly higher compared to control (Fig. 4A).
Quantitative reverse transcription polymerase chain reaction (RT-qPCR) analysis showed that the 
mRNA expression of HIF-2α, VEGF, plasminogen activator inhibitor-1 (PAI-1), BCL2/adenovirus E1B 19 
kDa-interacting protein 3 (Bnip3), type 1 collagen, and fibronectin was significantly higher in TECs treated with 
DOX at both concentrations than in untreated control TECs (Fig. 4B). Lysyl oxidase and phosphoglycerate kinase 
1 (PGK1) mRNA expression were significantly higher in TECs treated with DOX at 5 μg/mL but not at 1 μg/mL.
HIF-2α overexpression in isolated primary TECs affects the expression of various proteins 
in a time-dependent way. HIF-2α protein expression significantly increased as the DOX-treated time 
increased. According to the increase in HIF-2α protein expression, the protein expressions of fibronectin and 
type 1 collagen were also significantly upregulated in a time-dependent way. The ratio of p-p38/p38 was elevated 
in DOX-treated groups compared with control (Fig. 5).
TECs under hypoxia also induced fibronectin and type 1 collagen like HIF-2α- overexpressed 
TECs, but not via HIF-2α expression. HIF-2α protein expression did not increase in hypoxic TECs 
compared with control cells (Fig. 6A). However, HIF-1α expression significantly increased in hypoxic TECs 
compared to controls. Nevertheless, protein expressions of fibronectin and type 1 collagen were higher in both 
of DOX-treated and hypoxia-exposed TECs than those in controls. In addition, VEGF, fibronectin, and type 1 
Figure 2. Selective renal tubular HIF-2α activation has dual effects on renal fibrosis. (A) Western blot 
results (n = 3 for control, n = 6 for other groups). Representative images of 3 repeated western blot analysis 
and quantification. (B) Representative images of similar sections showing Masson’s trichrome and Sirius red 
stainings. Sirius red-stained sections were viewed with polarization contrast illumination, converted into gray-
scale images, and quantified using non-overlapping 10 × images over the entire kidney section (10 images 
per mouse, n = 2 for control, n = 7 for WT 2-week CKD group, n = 6 for other groups). The cropped blots are 
displayed; full-length blots are presented in Supplementary Fig. 5. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. 
controls; #P < 0.05, ##P < 0.01, and ###P < 0.001 between the two groups; bar graphs show mean ± SEM. Scale 
bars, 100 μm.
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collagen mRNA expressions were higher in both groups than those in controls (Fig. 6B). VEGF and fibronectin 
mRNA expressions were much higher in hypoxia-exposed TECs than those in DOX-treated TECs.
Human IgA nephropathy patients show distinct gene expression patterns according to the 
stage of tubular atrophy/interstitial fibrosis. Finally, we performed RT-qPCR analysis of a variety of 
relevant genes in microdissected renal tubulointerstitium of patients with IgA nephropathy. The subjects were 
divided according to the stage of tubular atrophy/interstitial fibrosis (T stage) by the Oxford classification. Renal 
HIF-2α, VEGF, fibronectin, and TGF-β mRNA expression was significantly higher in stage T1 than in stages T0 
and T2. In contrast, HIF-1α mRNA expression was significantly lower in stage T1 patients than in stage T2 sub-
jects. CTGF expression did not differ among the three groups (Supplementary Fig. 4A).
There were no significant differences in the gene expression patterns in the groups stratified by the CKD stage 
based on estimated glomerular filtration rate (eGFR) (Supplementary Fig. 4B).
Discussion
In this study, we found that renal tubular HIF-2α activation had dual effects on renal fibrosis according to the 
degree of tubulointerstitial hypoxia in a non-diabetic CKD model. When HIF-2α expression was induced at ini-
tiation of CKD, it played a predominantly profibrotic role. In contrast, HIF-2α activation at a later stage of CKD 
protected the kidney from the progression of renal fibrosis, resulting in functional preservation.
Figure 3. Renal vasculature and hypoxia were ameliorated with renal tubular HIF-2α activation. 
(A,B) Representative blot of 3 repeated western blot analysis for CD31 and representative images of 
immunofluorescent staining for CD31 (n = 3). (C) Representative images of immunohistochemical staining 
using pimonidazole (5 images per mouse, n = 2). The cropped blots are displayed; full-length blots are presented 
in Supplementary Fig. 5. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. controls; #P < 0.05, ##P < 0.01, and 
###P < 0.001 between the two groups; bar graphs show mean ± SEM. Scale bars, (B) 1000 μm and (C) 100 μm.
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Until now, some studies have explored the effects of individual HIFs on renal fibrosis, but it is not conclu-
sive yet. Global activation of HIF suppressed inflammation and fibrogenesis in UUO mice11. However, tubular 
cell-specific HIF-1 deletion using HIF-1α2lox/2lox:PEPCK-cre mice inhibited the development of renal tubuloin-
terstitial fibrosis in UUO mice3. In addition, continuous transgenic expression of HIF-2α by the Ksp-Cadherin 
promotor led to renal fibrosis and insufficiency, next to multiple renal cysts12. Administration of a prolyl hydrox-
ylase inhibitor induced HIF-1α at an early stage in a rat remnant kidney model, while HIF-2α expression was 
increased at moderately advanced stages4.
Although HIF-1α and HIF-2α are closely related and show 48% overall amino acid identity, they have dis-
tinct but partially overlapping functions10, 13. Therefore, it is likely that the effects of HIF activation on renal 
fibrosis in CKD may be different according to the HIF class. In response to hypoxia, proximal TECs stabilized 
HIF-1α, but not HIF-2α14. Moreover, HIF-1α and HIF-2α expression may be differential in intermittent hypoxia 
(IH)-associated disease; HIF-1α protein expression is induced during intermittent hypoxia (IH)15, 16, while 
HIF-2α expression is repressed by IH through calpain-dependent mechanisms17. In addition, whereas HIF-1α 
was inducible in physiological renal mouse, rat and human tubular epithelia, HIF-2α was never detected in these 
cells in any species, and tubular cells required VHL inactivation to allow HIF-2α expression12. Recently, how-
ever, cobalt chloride treatment increased HIF-2α as well as HIF-1α protein expression in HK-2 cells, and renal 
HIF-1α and HIF-2α protein expression was simultaneously upregulated with L-mimosine administration after 
ischemia-reperfusion injury18. If HIF-1α and HIF-2α expressions are induced in human renal tubular cells by 
non-specific HIF stabilizers, the results of this study may have the clinical relevance. In addition, we found that 
Figure 4. HIF-2α activation affects expression of various genes in cultured primary tubular epithelial cells 
(TECs). (A) After isolation of TECs from transgenic mice, doxycycline (DOX) was added to the media or not 
(control), and HIF-2α induction in TECs by DOX was confirmed by western blotting and immunofluorescent 
staining (n = 3). (B) In RT-qPCR for the mRNA (n = 3). qPCRs were performed 3 to 4 times with RNA isolated 
lysates derived from 3 independent cell culture experiments. The cropped blots are displayed; full-length 
blots are presented in Supplementary Fig. 5. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. controls; #P < 0.05, 
##P < 0.01, and ###P < 0.001 between the two groups; bar graphs show mean ± SEM. Scale bars, 20 μm.
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Figure 5. HIF-2α overexpression in isolated primary tubular epithelial cells (TECs) affects the expression 
of various proteins in a time-dependent way. Representative images of 3 repeated western blot analysis and 
quantification (n = 3). The cropped blots are displayed; full-length blots are presented in Supplementary Fig. 5. 
**P < 0.01 and ***P < 0.001 vs. controls; #P < 0.05, ##P < 0.01, and ###P < 0.001 between the two groups; bar 
graphs show mean ± SEM.
Figure 6. Protein and mRNA expressions changed similarly between doxycycline (DOX)-treated and 
hypoxia-exposed tubular epithelial cells (TECs). Representative images of 3 repeated western blot analysis 
and quantification (n = 3). qPCRs were performed 3 to 4 times with RNA isolated lysates derived from 3 
independent cell culture experiments. The cropped blots are displayed; full-length blots are presented in 
Supplementary Fig. 5. **P < 0.01, and ***P < 0.001 vs. controls; #P < 0.05, ##P < 0.01, and ###P < 0.001 between 
the two groups; bar graphs show mean ± SEM.
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TECs under hypoxia upregulated VEGF as well as fibronectin and type 1 collagen expressions as with tubular 
cells with HIF-2α activation. Since HIF-2α expression was hardly detected in hypoxia-exposed TECs, we assume 
that these effects were related to HIF-1α activation by hypoxic stimuli. However, both profibrotic and antihypoxic 
effect by HIF activation in TECs might be similar between HIF-1α and HIF-2α in case that HIF-1α or HIF-2α 
maintained in tubule cells at a sufficient concentration and time.
To our knowledge, this study is the first to investigate the consequences of tubular HIF-2α-selective acti-
vation using inducible tubule-specific transgenic mice. Tubular HIF-2α activation was directly associated with 
changes in renal function and tubulointerstitial fibrosis in CKD mice. In addition, the effect HIF-2α was different 
according to the activation timing in CKD. Administration of cobalt chloride for 1 week from the initiation of an 
ablation/infarction kidney model significantly reduced metabolic and hemodynamic abnormalities19. However, 
we surmised that HIF activation might be more beneficial at a later stage of CKD, because renal hypoxia can 
be worsened as CKD is progressive. In the present study, CKD mice had a significantly higher degree of renal 
hypoxia than control mice, and HIF-2α activation at a later stage of CKD mitigated renal hypoxia and abrogated 
renal dysfunction as well as the progression of fibrosis.
A previous report showed that HIF activation was not sufficient to overcome the hypoxic insult and did not 
sustain during the whole hypoxic period in longstanding CKD20. Therefore, renal cells cannot survive the hypoxia 
because of inadequate HIF stimuli in CKD. In fact, HIF-α activation using a prolyl hydroxylase inhibitor at a 
mid-advanced stage of CKD, but not at the early stage, resulted in an improvement in renal fibrosis and dys-
function4. In contrast, one study demonstrated that the effect of cobalt chloride on tubulointerstitial fibrosis in 
nephrectomized rats did not differ according to the timing of its administration9. The discrepancy between the 
findings in these two studies may in part be attributed to differences in the drugs used for HIF activation/stabi-
lization, research design, or the timing of HIF induction. In the current study, the timing of HIF-2α activation 
was a prime determinant of the phenotypic changes in the kidneys; renal fibrosis was aggravated when HIF-2α 
was activated from the beginning of CKD, while it was ameliorated via an improvement in renal hypoxia when 
HIF-2α was activated at a later stage of CKD. Accordingly, stabilization of both HIF1 and HIF2 in a 5/6 renal 
ablation model of VHL–/– mice was also associated with exacerbated renal fibrosis, and treatment with YC-1, 
an anti-HIF-1 agent, inhibited the progression of renal fibrosis in UUO model mice7. As VHL–/– mice likely 
expressed a high level of HIF when CKD was generated, a high HIF level at the initiation of renal fibrosis might 
induce the profibrotic pathway cascade. In addition, whole-body deletion of VHL induces HIF activation in all 
types of renal cells, and thus, specific consequences of HIF activation in the kidney might be masked. In fact, 
HIF-2α activation in podocytes resulted in crescentic glomerulonephritis21.
A PAX8 promoter was used in this study to confine HIF-2α activation within renal tubular cells, which are a 
main source of VEGF in the tubulointerstitium22. Decreased tubular VEGF expression is significantly associated 
with the severity of peritubular capillary loss19. Furthermore, peritubular capillary density is positively correlated 
with proximal tubular size and negatively with interstitial volume in the human kidney, suggesting that ischemia 
induced by peritubular capillary loss could exacerbate tubulointerstitial injury23. In our study, cultured TECs with 
activated HIF-2α had higher VEGF expression than control cells. Moreover, we found in vivo that VEGF mRNA 
expressions consistently decreased in wild-type CKD mice compared to controls after CKD induction. In con-
trast with the inconsistent results in mRNA expressions of transgenic CKD mice at 2 weeks between total VEGF 
and its isoform 120, 164, and 188, which are known to play a major role on angiogenesis in the kidney24, 25, those 
were significantly higher in HIF-2α transgenic mice at 4 weeks of CKD induction. Of note, they were the highest 
in transgenic mice with later HIF-2α activation among all groups. We suppose that VEGF mRNA expression in 
tubular cells may be affected not only by HIF-2α activation but also by the degree of tubulointerstitial hypoxia.
In parallel with the pattern of VEGF expression, peritubular vasculature as assessed by CD31 expression was 
not diminished in transgenic CKD mice with later HIF-2α activation compared with control. Based on these 
findings, we postulate that HIF-2α activation at a later stage can lead to sustained release of VEGF, resulting in 
maintenance of vascular integrity and attenuation of tubulointerstitial hypoxia.
HIF-2α activation also was associated with an increase in the mRNA expression of PGK1, which plays a key 
role in coordinating glycolytic energy production with one-carbon metabolism, serine biosynthesis, and cellular 
redox regulation26, collectively promoting tubular cells to survive under hypoxic conditions. Meanwhile, HIF-2α 
activation in cultured TECs also induced profibrotic and proapoptotic genes, including fibronectin, type 1 col-
lagen, PAI-1, lysyl oxidase, and Bnip3, indicating that they are under the control of HIF-2α. Similarly, HIF-2α 
activation from the initiation of CKD induced renal fibronectin and type 1 collagen expression at 2 and 4 weeks 
in vivo. In contrast, expressions of profibrotic genes along with renal dysfunction at 4 weeks were abrogated by 
HIF-2α activation at a later stage of CKD.
The exact underlying mechanism of selective tubular HIF-2α activation on renal fibrosis is inconclusive. 
Since the relationship between kidney fibrosis and mitogen-activated protein kinase (MAPK) pathway is well 
established27, we first evaluated p38 MAPK activation in TECs with HIF-2α activation, and found that phos-
phorylation of p38 MAPK was significantly associated with HIF-2α activation in TECs, suggesting that stim-
ulation of p38 MAPK pathway by HIF-2α activation is, at least in part, could be related to the induction of 
renal fibrosis.
Tubular cell is not the main contributor to the progression of renal fibrosis. Renal fibrosis is induced by the 
tubular cells, fibroblasts, pericytes, endothelial cells, and even bone marrow-derived cells28. In this study, renal 
fibrosis induced by tubular HIF-2α activation did not lead renal dysfunction. Although HIF-2α activation in 
TECs significantly increased fibronectin and type 1 collagen expressions in vitro and early tubular HIF-2α over-
expression in CKD mice increased their expressions in vivo, it was not associated with the deterioration in renal 
function assessed by BUN and creatinine level. Therefore, we suggest that profibrotic effects of HIF-2α activation 
in tubular cells is likely to be minor in the CKD progression.
www.nature.com/scientificreports/
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Sustained renal tubular HIF-2α expression must have detrimental effects29, which accords closely with our find-
ings. However, as aforementioned, HIF-2α activation at a later stage of CKD may reverse the deleterious impact of 
renal hypoxia by improvement of peritubular vascular integrity, and the positive effect may overcome the induction 
of profibrotic and proapoptotic genes by HIF-2α in tubule cells per se (Fig. 7). We need to consider overall effects of 
tubular HIF-2α activation on renal fibrosis and renal dysfunction in a body as a whole at a specific time.
Finally, we preliminarily investigated mRNA expression in the kidneys of IgA nephropathy patients according to 
the degree of tubular atrophy/interstitial fibrosis based on the Oxford classification. Interestingly, at stage T1, which is 
considered an early stage of renal fibrosis, the expression of multiple genes significantly differed from that at stages T0 
and T2. Expression of HIF-2α, fibronectin, and TGF-β was significantly increased at stage T1. However, at stage T2, 
HIF-2α mRNA upregulation was not sustained, which might have led to a decrease in VEGF mRNA expression. Based 
on these findings, we inferred that a sustained release of VEGF at a later stage of renal fibrosis via HIF-2α stabilization 
could relieve tubulointerstitial hypoxia and inhibit the progression of fibrosis. However, the optimal timing for HIF-2α 
stabilization for protection against renal fibrosis should be further elucidated. HIF-2α and VEGF mRNA levels were 
significantly correlated with the stage of tubular atrophy/interstitial fibrosis but not with the eGFR stage. Therefore, it 
would remain difficult to decide on the proper timing for HIF-2α stabilization in clinical practice. In addition, although 
it has been recently reported that hypoxic HIF-2α protein expression can be transcriptionally regulated via insulin-like 
growth factor-II in some tumor cell lines30, 31, the expression of HIF-α subunits depends on the post-translational 
process. Therefore, further studies are necessary to elucidate whether the change in HIF-2α mRNA expression in the 
human kidney would result in altered protein expression of HIF-2α and phenotypic change.
There are some limitations in this study. First, we induced renal fibrosis and CKD by 0.2% adenine-containing 
diet. This CKD model was verified by other investigators. Administration of 0.2% adenine diet increased BUN 
and serum creatinine levels, and induced renal fibrosis and tissue hypoxia32, 33. However, it may not be the classic 
CKD model as 5/6 nephrectomized animal and we cannot totally exclude the chemical effect of adenine on our 
findings. Second, HIF-2α protein expression in kidneys was not significantly higher in CKD mice compared 
to controls, and hypoxia did not induce HIF-2α activation in TECs in this study. Therefore, the role of HIF-2α 
overexpression in CKD still remains to be elusive. Finally, we did not evaluate the effect of administration of 
non-specific HIF stabilizers on CKD. Therefore, it is still uncertain that the findings in this study could be extrap-
olated to clinical relevance, and further studies are necessary whether HIF stabilizers are able to overexpress 
HIF-2α in TECs and whether overexpression of HIF-1α in TECs has similar effects to HIF-2α.
Taken together, renal tubular HIF-2α activation at the beginning of CKD aggravated renal fibrosis, whereas 
at a later stage of CKD, it inhibited the progression of renal fibrosis and improved renal function. Therefore, renal 
HIF-2α activation could represent a therapeutic target in late-stage CKD.
Methods
Animals. Animal care and use protocols for all experiments of this study were reviewed and approved by the 
IACUC at School of Medicine, Ewha Womans University (ESM 12-0201, ESM14-0265). All methods were per-
formed in accordance with the relevant guidelines and regulations.
We used a transgenic mouse line containing hemagglutinin (HA)-tagged HIF2dPA, which escapes from rec-
ognition by pVHL owing to a proline to alanine substitution, preceded by a floxed stop codon cassette, rendering 
HIF-2α expression Cre-dependent10. Transgenic mice, which carried the three transgenes were generated by 
multiple breeding strategies (Fig. 1A), and progeny without all three transgenes were regarded wild-type. Given 
the large number of transgenes and complex breeding strategies, the genetic background strain for all mice used 
Figure 7. Schematic diagram for the dual effect of HIF-2α on renal fibrosis in chronic kidney disease (CKD). 
Net effect of tubule-specific stabilization of HIF-2α to the kidney is dependent on the degree of tubulointerstitial 
hypoxia. Although HIF-2α stimulation activates both antihypoxic pathway and profibrotic pathway, its net 
effect on renal fibrosis and the resultant renal dysfunction is different according to activated timing of HIF-2α. 
ECM, extracellular matrix; PTCs, peritubular capillaries.
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in this study was mixed. HIF-2α protein expression could be determined by western blotting or immunofluores-
cent staining with anti-HA antibody (sc-805; Santa Cruz Biotechnology Inc., Dallas, TX, USA) or anti-HIF-2α 
antibody (NB100-122; Novus biologicals Inc., Littelton, CO, USA). To obtain renal tubular cell-specific HIF-
2α-overexpression at the time of choice, DOX (Sigma Chemical Co., St. Louis, MO, USA) was added to the 
drinking water at a concentration of 2 mg/mL for at least 3 days.
For the induction of renal fibrosis and CKD, the mice were fed a custom-made diet (Central Lab Animal Inc., 
Korea) containing 0.2% (w/w) adenine (A2786; Sigma Chemical Co.) for 2 or 4 weeks32. In addition, renal hypoxia 
measured by pimonidazole staining was effectively induced by 0.2% adenine-containing diet33. Transgenic and 
wild-type mice were divided into 6 experimental groups: (i) wild-type mice fed a standard diet (control), (ii) 
wild-type mice fed adenine-containing diet for 2 weeks, (iii) transgenic mice fed adenine-containing diet for 2 
weeks with DOX administration at day 0, (iv) wild-type mice fed adenine-containing diet for 4 weeks, (v) trans-
genic mice fed adenine-containing diet for 4 weeks with DOX administration at day 0, and (vi) transgenic mice 
fed adenine-containing diet for 4 weeks with DOX administration at day 14. Mice were sacrificed at 2 or 4 weeks, 
and the kidneys were removed for histological evaluation and molecular analysis.
We detected quantitatively hypoxia gradients in animals with a hypoxyprobe™-1 (pimonidazole HCl; 
Hypoxyprobe Inc., Burlington, MA, USA) solution. Paraffin-embedded kidneys were stained with Masson’s 
trichrome for qualitative evaluation of renal fibrosis, and stained with Picro-Sirius Red (ab150681; Abcam, 
Cambridge, UK) for quantitative analysis of fibrosis. Then, we performed immunofluorescent staining with 
paraffin-embedded kidney sections, which were incubated with primary antibodies against hemagglutinin (sc-
805; Santa Cruz Biotechnology Inc., Dallas, TX, USA), anti-HIF-2α antibody (NB100-122; Novus biologicals Inc., 
Littelton, CO, USA), and CD31 (MAB1398Z, EMD Millipore Co., Temecula, CA, USA).
Isolation and Culture of Renal Tubular Epithelial Cells (TECs). Primary renal TECs were isolated 
from PAX8-rtTA/tetO-Cre/HIF2dPA-HA transgenic male mice aged 4 weeks or less. For HIF-2α induction in 
cultured renal TECs, DOX was added into the media at a final concentration of 1 μg/mL or 5 μg/mL to reveal the 
dose-dependent HIF-2α effect. DOX (5 μg/mL) was also supplied into the media with the course of time (6-, 12-, 
24-, and 48-hr) to show the time-dependent HIF-2α effect. In addition, hypoxia-exposed TECs were used to 
investigate endogenous HIF-2α expression and its relevant gene expressions.
Molecular Analysis. We performed western blot analysis for the evaluation of fibronectin (rabbit, 1:1000; 
Dako), CD31 (rabbit; 1:1000; ab28364, Abcam), HIF-2α (rabbit; 1:500; NB100-122, Novus Biologicals Inc.), type 
1 collagen (goat; 1:1000; 1310-01, Southernbiotech), p38 (rabbit; 1:1000, cell signaling), p-p38 (rabbit; 1:1000, 
cell signaling), and β-actin (mouse; 1:1000; A5441, Sigma Chemical Co.) protein expression. The relative mRNA 
expression levels were determined as ratios relative to control levels using quantitative reverse transcriptase pol-
ymerase chain reaction (RT-qPCR) analysis, and the sequences of primers used for the experiment are presented 
in Supplementary Table 1.
Analysis in Human Subjects. Eight adult patients with IgA nephropathy (all male; median age, 49; median 
MDRD eGFR, 27.3 mL/min per 1.73 m2; median albumin-to-creatinine ratio, 568.7 mg/g) confirmed by renal 
biopsy were included. Kidney tissues were collected after obtaining the approval from the Institutional Review 
Board (IRB) of Yonsei University Heath System Clinical Trial Center (IRB No; 4-2006-0154), and all participants 
provided written informed consent.
We microdissected the renal tissue of patients, used tubulointerstitium for RT-qPCR analysis of a variety of 
relevant genes, and compared mRNA expression patterns according to stage of tubular atrophy/interstitial fibrosis 
(T stage) by the Oxford classification or according to the CKD stage based on the estimated glomerular filtration 
rate. The sequences of primers used for the experiment are presented in Supplementary Table 2.
Equipment and Settings. Images of the stained tissues were captured under a polarized microscope (BX51 
microscope; Olympus, Tokyo, Japan) and converted into gray-scale images for quantification. In addition, immu-
nofluorescent mages were acquired using a confocal laser-scanning microscope (LSM5 PASCAL; Carl Zeiss Jena 
GmbH, Jena, Germany). And, all digitized images submitted with the final revision of the manuscript was 300 
DPI. Moreover, the Anaeropack-anaero (< 1% O2 and 5% CO2; Mitsubishi Gas Chemical Co., Tokyo, Japan) 
was used to create a hypoxic condition. All images were submitted to Image J v1.49 (NIH, Bethesda, MD, USA) 
to quantify the percentage of fibrosis in total tissue within an image. Furthermore, all the methods were carried 
out in accordance with relevant guidelines and regulations, and all the experimental protocols were approved by 
School of Medicine, Ewha Womans University and Yonsei University Health System.
Statistical Analysis. All values are expressed as the mean ± standard error of the mean (SEM). Statistical 
analysis was performed using PRISM 6.0 software (GraphPad, San Diego, CA, USA) and the statistic software 
SPSS, ver. 18.0 (SPSS Inc., Chicago, IL, USA). ANOVA with Fisher’s least significant difference (LSD) post hoc test 
was used for multiple comparisons. Student’s t test was performed to compare differences between two groups. 
P-values less than 0.05 were considered to be statistically significant.
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